Pathogenic role of the gut microbiota in gastrointestinal diseases

by Hiroko Nagao-Kitamoto, Sho Kitamoto, Peter Kuffa, Nobuhiko Kamada
Published 2016-04-01

Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1.

by Yukihiro Matsunoshita, Kosei Ijiri, Yasuhiro Ishidou, Satoshi Nagano, Takuya Yamamoto, Hiroko Nagao, Setsuro Komiya, Takao Setoguchi
Published 2011-01-01

Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation.

by Shunsuke Nakamura, Satoshi Nagano, Hiroko Nagao, Yasuhiro Ishidou, Masahiro Yokouchi, Masahiko Abematsu, Takuya Yamamoto, Setsuro Komiya, Takao Setoguchi
Published 2013-01-01

RBPJ is a novel target for rhabdomyosarcoma therapy.

by Hiroko Nagao, Takao Setoguchi, Sho Kitamoto, Yasuhiro Ishidou, Satoshi Nagano, Masahiro Yokouchi, Masahiko Abematsu, Naoya Kawabata, Shingo Maeda, Suguru Yonezawa, Setsuro Komiya
Published 2012-01-01

Development of Immortalized Human Tumor Endothelial Cells from Renal Cancer

by Nako Maishi, Hiroshi Kikuchi, Masumi Sato, Hiroko Nagao-Kitamoto, Dorcas A. Annan, Shogo Baba, Takayuki Hojo, Misa Yanagiya, Yusuke Ohba, Genichiro Ishii, Kenkichi Masutomi, Nobuo Shinohara, Yasuhiro Hida, Kyoko Hida
Published 2019-09-01

Functional Characterization of Inflammatory Bowel DiseaseâAssociated Gut Dysbiosis in Gnotobiotic MiceSummary

by Hiroko Nagao-Kitamoto, Andrew B. Shreiner, Merritt G. Gillilland, III, Sho Kitamoto, Chiharu Ishii, Akiyoshi Hirayama, Peter Kuffa, Mohamad El-Zaatari, Helmut Grasberger, Anna M. Seekatz, Peter D.R. Higgins, Vincent B. Young, Shinji Fukuda, John Y. Kao, Nobuhiko Kamada
Published 2016-07-01